Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.3389/FCIMB.2021.794610 | ||||
| Año | 2021 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
The gut microbiome has been linked to breast cancer via immune, inflammatory, and hormonal mechanisms. We examined the relation between adolescent breast density and gut microbial composition and function in a cohort of Chilean girls. This cross-sectional study included 218 female participants in the Growth and Obesity Cohort Study who were 2 years post-menarche. We measured absolute breast fibroglandular volume (aFGV) and derived percent FGV (%FGV) using dual energy X-ray absorptiometry. All participants provided a fecal sample. The gut microbiome was characterized using 16S ribosomal RNA sequencing of the V3-V4 hypervariable region. We examined alpha diversity and beta diversity across terciles of %FGV and aFGV. We used MaAsLin2 for multivariable general linear modeling to assess differential taxa and predicted metabolic pathway abundance (MetaCyc) between %FGV and aFGV terciles. All models were adjusted for potential confounding variables and corrected for multiple comparisons. The mean %FGV and aFGV was 49.5% and 217.0 cm(3), respectively, among study participants. Similar median alpha diversity levels were found across %FGV and aFGV terciles when measured by the Shannon diversity index (%FGV T1: 4.0, T2: 3.9, T3: 4.1; aFGV T1: 4.0, T2: 4.0, T3: 4.1). %FGV was associated with differences in beta diversity (R-2 = 0.012, p=0.02). No genera were differentially abundant when comparing %FGV nor aFGV terciles after adjusting for potential confounders (q > 0.56 for all genera). We found no associations between predicted MetaCyc pathway abundance and %FGV and aFGV. Overall, breast density measured at 2 years post-menarche was not associated with composition and predicted function of the gut microbiome among adolescent Chilean girls.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Yoon, Lara | Mujer |
UNIV CALIF LOS ANGELES - Estados Unidos
UCLA Fielding School of Public Health - Estados Unidos |
| 2 | Jacobs, Jonathan P. | Hombre |
UNIV CALIF LOS ANGELES - Estados Unidos
Vet Adm Greater Los Angeles Healthcare Syst - Estados Unidos UCLA Fielding School of Public Health - Estados Unidos David Geffen School of Medicine at UCLA - Estados Unidos VA Greater Los Angeles Healthcare System - Estados Unidos |
| 3 | Hoehner, Jessica | Mujer |
Leidos Inc - Estados Unidos
|
| 4 | PEREIRA-SCALABRINO, ANA INES | Mujer |
Universidad de Chile - Chile
|
| 5 | GANA-ANSALDO, JUAN CRISTOBAL | Hombre |
Pontificia Universidad Católica de Chile - Chile
|
| 6 | Corvalan, Camila | Mujer |
Universidad de Chile - Chile
|
| 7 | Michels, Karin B. | Mujer |
UNIV CALIF LOS ANGELES - Estados Unidos
Univ Freiburg - Alemania UCLA Fielding School of Public Health - Estados Unidos Universitätsklinikum Freiburg - Alemania |
| Fuente |
|---|
| National Institutes of Health |
| Emory University |
| National Institute of Environmental Health Sciences |
| National Cancer Institute |
| U.S. Department of Veterans Affairs |
| National Center for Advancing Translational Sciences |
| Albert-Ludwigs-Universität Freiburg |
| School of Medicine, Emory University |
| Karen Toffler Charitable Trust |
| Baden-Wuerttemberg Ministry of Science, Research and Art |
| National Institute of Environmental Health |
| Agradecimiento |
|---|
| This research was supported by research grant U01ES026130 from the National Institute of Environmental Health and the National Cancer Institute, National Institutes of Health (to KBM). This research was also supported by the National Institute of Environmental Health Sciences of the National Institutes of Health under Award Number U2CES026560 to Emory University and the Emory Integrated Computational Core (EICC), which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities. Additional support was provided by the National Center for Georgia Clinical & Translational Science Alliance of the National Institutes of Health under Award Number UL1TR002378. LSY was supported by T32 training grant 5T32CA009142 from the National Cancer Institute, National Institutes of Health and the Karen Toffler Charitable Trust. JPJ was supported by VA CDA2 IK2CX001717. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health. The article processing charge was funded by the Baden-Wuerttemberg Ministry of Science, Research and Art and the University of Freiburg in the funding programme Open Access Publishing. |